CRC
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved Lumakras with Vectibix for adult patients with KRAS G12C–mutated metastatic colorectal ...
JANUARY 21, 2025
Erbitux Approved for Use With Braftovi for BRAF V600E–Mutated mCRC
The FDA granted approval of a new indication for cetuximab (Erbitux, Lilly) in combination with encorafenib ...
OCTOBER 4, 2021
Braftovi Approved to Treat BRAF-Mutated CRC in Combination With Erbitux
The FDA approved the use of encorafenib (Braftovi, Pfizer) in combination with cetuximab (Erbitux, ImClone) in ...
APRIL 21, 2020
An Aspirin a Day Keeps CVD and CRC At Bay
The U.S. Preventive Services Task Force issued recommendations based on age and risk for the use of aspirin for ...
APRIL 13, 2016
Load more